Doing journalist: Boundary markers for division, jurisdiction markers for belonging
Communication Theory · 05.11.2026
DOI: 10.1093/ct/qtag024 ↗Kurz gefasst
Fachartikel in der Zeitschrift Communication Theory, online erschienen am 05.11.2026. Verfasst von Lea von den Driesch und 2 weiteren Autor:innen. Die Arbeit nennt 77 Literaturangaben.
Abstract (Originalsprache)
Peripheral actors are often seen as a threat to journalists’ professional status and resources. Research so far has mainly focused on journalists’ discursive responses and the use of “boundary markers.” However, audiences often struggle to recognize such distinctions. To understand the strategic efforts and successes of peripheral actors, it is necessary to examine: (1) how these actors claim jurisdiction and authority through their performances; and (2) what makes their claims persuasive to publics. Drawing on symbolic interactionist perspectives, we propose a framework that distinguishes doing journalist—in contrast to doing journalism—building on West and Zimmerman’s notion of doing gender. Both practices aim to secure ascriptions of jurisdiction and authority from audiences. We illustrate the framework’s applicability with two prominent cases—from Germany (Fabian Grischkat) and the US (V Spehar)—and suggest its broader applicability (e.g., doing scientist alongside doing science or doing artist alongside doing art).
Zitieren
APA
Driesch, L. V. D., Springer, N., & Lewis, S. C. (2026). Doing journalist: Boundary markers for division, jurisdiction markers for belonging. Communication Theory. https://doi.org/10.1093/ct/qtag024
Vancouver
Driesch LVD, Springer N, Lewis SC. Doing journalist: Boundary markers for division, jurisdiction markers for belonging. Communication Theory. 2026. doi:10.1093/ct/qtag024
BibTeX
@article{Driesch2026,
author = {Driesch, Lea von den and Springer, Nina and Lewis, Seth C},
title = {Doing journalist: Boundary markers for division, jurisdiction markers for belonging},
journal = {Communication Theory},
year = {2026},
doi = {10.1093/ct/qtag024}
}
EUVIMED